FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to pharmaceutics and concerns an interferon-inducing agent for treating acute respiratory viral infections and represents 1-{[6-brom-1- methyl-5-methoxy-2-phenylthiomethyl-1-n-indol-3-yl]carbonyl}-4-benzylpiperazine hydrochloride.
EFFECT: invention provides the agent showing interferonogenic action and applicable for treating acute respiratory viral infections (ARVIs).
12 tbl, 3 ex
Title | Year | Author | Number |
---|---|---|---|
INTERFERON-INDUCING AGENT FOR TREATING ACUTE RESPIRATORY VIRAL INFECTIONS (ARVD) | 2010 |
|
RU2470634C2 |
ANTI-VIRAL IMMUNOTROPIC AGENT FOR TREATMENT OF ARVI | 2018 |
|
RU2672888C1 |
DRUG POSSESSING INTERFERON-INDUCING AND IMMUNOMODULATING (IMMUNOSTIMULATING) ACTIVITY | 1987 |
|
RU2033157C1 |
AGENT SHOWING EFFECT WITH RESPECT TO INFECTIOUS AGENTS | 1994 |
|
RU2092177C1 |
PROLONGED-EFFECT INTERFERON INDUCTOR | 1999 |
|
RU2172631C2 |
USE OF LIOPHILISED PREPARATION OF ALLOFIBROBLASTS FOR TREATING HERPES VIRUS DISEASES | 2012 |
|
RU2483739C1 |
ANTIVIRAL AGENT | 2014 |
|
RU2564919C1 |
INTERFERON INDUCING AGENT | 1998 |
|
RU2132681C1 |
DRUG FOR TREATMENT OF PATIENTS WITH VIRAL DISEASE | 1994 |
|
RU2118163C1 |
WATER-SOLUBLE ANTIVIRAL AND IMMUNOMODULATIORY DRUG BASED ON IONIC SILVER AND METHYLENE BLUE COMPOUND AND METHOD FOR PREPARING THEREOF | 2008 |
|
RU2390343C1 |
Authors
Dates
2012-03-20—Published
2010-10-05—Filed